---
title: "Huayou Cobalt: Company Has Received Export Approvals for Concentrate, Transit Period Approximately 3 Months"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283308128.md"
description: "At the 2025 Annual Results and Q1 2026 Performance Presentation Meeting, Huayou Cobalt announced that it has obtained export approvals for lithium concentrate, with an estimated transit period to China of approximately three months. The company primarily produces lithium concentrate and lithium sulfate in Zimbabwe. Although raw material shortages for lithium carbonate in Guangxi may occur, they are not expected to have a significant impact"
datetime: "2026-04-20T07:16:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283308128.md)
  - [en](https://longbridge.com/en/news/283308128.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283308128.md)
---

# Huayou Cobalt: Company Has Received Export Approvals for Concentrate, Transit Period Approximately 3 Months

On April 20, at Huayou Cobalt's 2025 Annual Results and Q1 2026 Performance Presentation Meeting on cash dividends, Company President Chen Hongliang stated that companies currently developing lithium resources in Zimbabwe have obtained export approvals for lithium concentrate, and all are currently undergoing processing procedures. Huayou Cobalt mainly produces two types of products in Zimbabwe: lithium concentrate and lithium sulfate. Once all export procedures are fully completed, the transit period to China will take approximately three months. While there may be potential shortages of raw materials for lithium carbonate in Guangxi, this is not expected to cause significant impact. (Shanghai Securities News)

### Related Stocks

- [603799.CN](https://longbridge.com/en/quote/603799.CN.md)

## Related News & Research

- [China's Huayou Cobalt Falls After Indonesian JV Agrees to Build NEV Battery Supply Chain With Local SOEs](https://longbridge.com/en/news/274485000.md)
- [China's Huayou Cobalt to Buy Australian Owner of Lithium Mine in Ghana for USD210 Million](https://longbridge.com/en/news/285511555.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Zimbabwe tobacco hits new highs under smallholder contracts](https://longbridge.com/en/news/286517314.md)
- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)